Trial
NCT03703908
A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Amgen
Collaborators
—
Condition
Focal Segmental Glomerulosclerosis
Intervention
CCX140-B
Why stopped
Program not advancing
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-17